Latest news with #MarcSteinberg
Yahoo
28-05-2025
- Business
- Yahoo
Honeywell, Joby, Fannie Mae & Freddie Mac: Trending Tickers
Honeywell (HON) adds Elliott Investment Management's Marc Steinberg to its board, according to the Wall Street Journal, ahead of the company's plans to split into three separate entities. Electric vertical take-off and landing — or eVTOL — developer Joby Aviation (JOBY) receives the first $250 million of Toyota's (TM, 7203.T) $500 million investment. Also watch Yahoo Finance's interview with Joby Aviation CEO JoeBen Bevirt from October 2024. President Trump says he plans to take US mortgage lenders Freddie Mac (FMCC) and Fannie Mae (FNMA) public, affirming that he will keep government guarantees. Catch Whalen Global Advisors Chairman Chris Whalen weigh in on the restructuring these two firms may need to see from the Trump administration for successful public spin-offs. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
28-05-2025
- Business
- Bloomberg
Honeywell Enters Cooperation Pact With Elliott Before Breakup
Honeywell International Inc. agreed to cooperate with Elliott Investment Management and add a member of the activist shareholder to its board as the industrial firm prepares to split into three companies. Honeywell named Marc Steinberg, a partner at Elliott, as an independent director and audit committee member, the Charlotte, North Carolina-based manufacturer said in a statement on Wednesday. The appointment is effective May 31.
Reuters
28-05-2025
- Business
- Reuters
Honeywell expected to add Elliott's Marc Steinberg to board, WSJ reports
May 28 (Reuters) - Honeywell (HON.O), opens new tab is expected to add activist Elliott Investment Management's Marc Steinberg to its board at the end of May, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Yahoo
07-05-2025
- Business
- Yahoo
Charles River Labs Stock Soars as Firm Shakes Up Board, Launches Review
Thomas Fuller / SOPA Images / LightRocket via Getty Images Key Takeaways Charles River Laboratories made changes in its board and announced a strategic review as it faced pressure from Elliott Investment Management. The medical testing firm will add four new board members, and four current members won't run for reelection. Elliott, the company's biggest shareholder, called the steps being taken "the right ones" to boost the value of Charles River. Charles River Laboratories (CRL) shares soared 16% to lead S&P 500 gainers Wednesday morning as the medical testing company announced a shakeup of its board and launched a strategic review of its operations after being pressured by activist investor Elliott Investment Management. Charles River's board agreed to bring on four new directors, as four current members won't seek reelection. Following the changes, which will come at the May 20 annual meeting, the company will have 11 directors, nine of whom independent. The board also authorized "a comprehensive strategic review and evaluation of Charles River's business and prospects, including an examination of various alternatives to enhance long-term stockholder value." In addition, Charles River said that it has signed a cooperation deal with Elliott, its largest shareholder, in which Elliott "has agreed to customary standstill, voting, confidentiality, and other provisions." 'Substantial Opportunity' Exists to Unlock Value, Elliott Partner Says Partner Marc Steinberg noted that Elliott believes Charles River's "current value is significantly disconnected from its underlying potential," and a "substantial opportunity" exists to unlock that value. Steinberg explained that these new moves by the company "are the right ones." Shares of Charles River Laboratories sank to a more than six-year low last month, and even with today's gains they remain down more than 25% year-to-date. TradingView Read the original article on Investopedia
